Data / Form D filings / Estuary Biotherapeutics, Inc.
Estuary Biotherapeutics, Inc.: Form D filing
Estuary Biotherapeutics, Inc., a biotechnology company in Menlo Park, CA, filed a Form D with the SEC in 2026. The latest, on October 16, 2026, reports $40.7 million sold of a $103.7 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 325 SHARON PARK DRIVE, #1020, Menlo Park, CA, 94025
- Phone
- (650) 275-3840
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2138862
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16 | New notice | $103,654,385 | $40,654,685 | $62,999,700 | 25 | Jul 1 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wayne E. Sackett | Executive Officer, Director | |
| Jacob Bauer | Director | |
| Owen Smith | Director | |
| Emily Minkow | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Theravie Pharma, Inc. $750,000 · Oct 19
- Adela, Inc. $12 million · Oct 19
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
- Lionheart Health, Inc. $387,500 · Oct 7
Every Form D from the week of Oct 12 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Estuary Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.